Ask Reg about: venture funds, research into neurodegenerative & aging-related disease
Dr. Regis B. Kelly is the Executive Director of QB3, one of the four Governor Gray Davis Institutes for Science and Innovation. Scientists on the three QB3 campuses (UCB, UCSC & UCSF) working at the interface of the physical and biological sciences. The QB3 innovation team converts discoveries into practical benefits for society. As Director, Dr. Kelly helped launch two QB3-associated companies, QB3@953, a life sciences startup incubator, and Mission Bay Capital, a venture fund. As a result of his experiences, Dr. Kelly was appointed as Senior Advisor on Innovation and Entrepreneurship to the President of the University, Janet Napolitano.
Prior to joining QB3 in 2004, Regis Kelly served as executive vice-chancellor at UCSF and chairman of the Department of Biochemistry and Biophysics. He holds the inaugural Byers Family Distinguished Professorship. His academic research was in the field of molecular and cellular neurobiology. His training was at Harvard, Stanford, Caltech and the University of Edinburgh. He has served on many national and international boards. In 2014 he was appointed an officer of the Order of the British Empire (OBE) for services to science, innovation, and global health.